HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
3.830
-0.170 (-4.25%)
At close: Jul 20, 2026, 4:00 PM EDT
4.000
+0.170 (4.44%)
Pre-market: Jul 21, 2026, 6:08 AM EDT
HCW Biologics Earnings Call Transcripts
Fiscal Year 2026
-
Key milestones included $17.5M equity raised, debt repayment, and clinical trial progress. Five shareholder proposals were approved, including director elections, auditor ratification, and warrant-related actions. Strategic focus remains on advancing clinical programs and business development.
Fiscal Year 2025
-
The meeting highlighted recent financial achievements, including new funding, debt conversion, and revenue recognition. Strategic clinical and business development initiatives were outlined, and key governance matters were addressed, with one director elected and the accounting firm ratified.